Status:
COMPLETED
Observational Study in Patients With Nail Psoriasis Treated With Enstilar® to Assess the Severity Change and the Quality of Life
Lead Sponsor:
Angeles Florez
Conditions:
Nail Psoriasis
Eligibility:
All Genders
18+ years
Brief Summary
Observational, prospective and multicentre study to evaluate the effectiveness of calcipotriene and betamethasone dipropionate aerosol foam (Cal / BD), prescribed according to clinical practice and fo...
Eligibility Criteria
Inclusion
- Patients with nail psoriasis who start, according to clinical practice, topical treatment with calcipotriene and betamethasone dipropionate aerosol foam
- Patients who authorize their participation in the study by signing written informed consent.
Exclusion
- Patients receiving treatment with systemic drugs or their prescription is scheduled for the next 3 months. However, may be included patients who receive the same systemic treatment regimen from at least 6 months before their inclusion in the study and up to 14 weeks later.
- Patients with any situation or state that in the opinion of the investigator discourages their participation in the study.
Key Trial Info
Start Date :
March 26 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 30 2021
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04380597
Start Date
March 26 2019
End Date
July 30 2021
Last Update
August 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Complejo Hospitalario Universitario de Pontevedra
Pontevedra, Spain, 36001